| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.31▼ | 1.32▼ | 1.32▼ | 1.38▼ | 1.27▲ |
| MA10 | 1.32▼ | 1.33▼ | 1.34▼ | 1.38▼ | 1.30▲ |
| MA20 | 1.35▼ | 1.42▼ | 1.43▼ | 1.26▲ | 1.36▼ |
| MA50 | 1.42▼ | 1.35▼ | 1.32▼ | 1.31▼ | 1.36▼ |
| MA100 | 1.32▼ | 1.26▲ | 1.28▲ | 1.39▼ | 1.67▼ |
| MA200 | 1.25▲ | 1.34▼ | 1.36▼ | 1.43▼ | 2.64▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.020▼ | -0.023▼ | 0.015▲ | -0.004▼ |
| RSI | 33.532▼ | 39.313▼ | 41.417▼ | 50.507▲ | 48.144▼ |
| STOCH | 9.259▼ | 22.022 | 17.161▼ | 57.149 | 28.856 |
| WILL %R | -55.556 | -89.189▼ | -93.103▼ | -58.377 | -61.194 |
| CCI | -61.111 | -67.818 | -73.236 | -5.528 | -3.155 |
|
Sunday, August 30, 2026 06:36 PM
August has been a great month for the shares of Merck & Co., Inc. (NYSE:MRK) and Moderna Inc. (NASDAQ:MRNA), to say the least.
|
|
Sunday, August 30, 2026 05:15 AM
Merck (NYSE:MRK) and Moderna report the first positive Phase 3 results for an individualized mRNA neoantigen cancer therapy in melanoma patients. The therapy was tested in combination with Merck's ...
|
|
Thursday, August 27, 2026 01:10 PM
Research productivity and cash generation remain important operating signals. Merck remains under focus as oncology momentum, pipeline development, research productivity, commercial execution and cash ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/09/26 | 1.29 | 1.335 | 1.29 | 1.31 | 18,831 |
| 31/08/26 | 1.37 | 1.405 | 1.33 | 1.33 | 59,484 |
| 28/08/26 | 1.50 | 1.50 | 1.35 | 1.37 | 84,406 |
| 27/08/26 | 1.45 | 1.50 | 1.4001 | 1.46 | 24,506 |
| 26/08/26 | 1.52 | 1.5905 | 1.45 | 1.45 | 33,826 |
| 25/08/26 | 1.50 | 1.59 | 1.475 | 1.52 | 146,617 |
| 24/08/26 | 1.46 | 1.50 | 1.46 | 1.495 | 236,307 |
| 21/08/26 | 1.25 | 1.4399 | 1.25 | 1.39 | 99,043 |
| 20/08/26 | 1.28 | 1.2863 | 1.19 | 1.22 | 79,707 |
| 19/08/26 | 1.19 | 1.36 | 1.175 | 1.29 | 230,069 |
|
|
||||
|
|
||||
|
|